An analysis today of pooled data from five US surveillance studies across three flu seasons in children found that the inhaled quadrivalent live attenuated influenza vaccine (LAIV) wasn’t as effective as the injectable version of the vaccine against the 2009 H1N1 strain.

Read more at CIDRAP

See also:                              

Jan 7 Pediatrics abstract

Jan 7 Pediatrics commentary